Letter: effectiveness of ustekinumab or vedolizumab in Crohn's disease following anti‐TNF failure—getting closer to the truth. Authors' reply

LINKED CONTENT This article is linked to Biemans et al and Liu et al papers. To view these articles, visit https://doi.org/10.1111/apt.15745 and https://doi.org/10.1111/apt.16009

Saved in:
Bibliographic Details
Published inAlimentary pharmacology & therapeutics Vol. 52; no. 7; pp. 1255 - 1256
Main Authors Biemans, Vince B. C., Hoentjen, Frank, Pierik, Marieke J.
Format Journal Article
LanguageEnglish
Published Chichester Wiley Subscription Services, Inc 01.10.2020
Subjects
Crohn's disease
Monoclonal antibodies
Online AccessGet full text

Cover

More Information
Summary:LINKED CONTENT This article is linked to Biemans et al and Liu et al papers. To view these articles, visit https://doi.org/10.1111/apt.15745 and https://doi.org/10.1111/apt.16009
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ObjectType-Commentary-2
ISSN:0269-2813
1365-2036
DOI:10.1111/apt.16062